US Edition
Published • loading... • Updated
Editas Medicine (NASDAQ:EDIT) Releases Earnings Results, Beats Expectations By $0.21 EPS
Summary by tickerreport.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Editas Medicine (NASDAQ:EDIT) Releases Earnings Results, Beats Expectations By $0.21 EPS
Editas Medicine (NASDAQ:EDIT – Get Free Report) posted its quarterly earnings results on Monday. The company reported ($0.06) earnings per share for the quarter, topping the consensus estimate of ($0.27) by $0.21, FiscalAI reports. The firm had revenue of $24.74 million for the quarter, compared to the consensus estimate of $8.77 million. Editas Medicine had […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
